- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.09. | PhRMA launches ad campaign urging Congress to address '340B medicine mark-ups' | ||
| 03.09. | AstraZeneca, exiting production digs in India, surrenders local manufacturing license | ||
| 03.09. | UK pharma trade group pushes for overhaul of government evaluation of life sciences investments | ||
| 03.09. | RFK Jr. critic Paul Offit iced out of key FDA vaccine panel | ||
| 03.09. | BD re-ups 'Love Your Limbs' campaign to boost peripheral artery disease diagnosis | ||
| 02.09. | Novartis plots 58 layoffs in New Jersey amid ongoing efficiency drive | ||
| 02.09. | United plots Tyvaso lung disease expansion with 'overwhelmingly positive' trial win | ||
| 02.09. | Novo's Wegovy tops Lilly's Zepbound at curbing cardio risks in real-world study | ||
| 02.09. | Ionis hits it out of the park with data for Tryngolza in severe blood fat disease | ||
| 02.09. | Merck, Bayer's Verquvo posts perplexing trial fail in patients with stable HFrEF | ||
| 02.09. | CapVest Partners snaps up German generics maker Stada, cancelling out prior IPO plans | ||
| 02.09. | Unichem Pharma recalls muscle relaxant bottles after labeling error | ||
| 02.09. | Regulatory tracker: FDA recommends additional MRI for patients receiving Leqembi | ||
| 29.08. | Physician enthusiasm for Novo's Wegovy suggests 'swift' uptake in Rezdiffra-dominated MASH market: Spherix | ||
| 29.08. | Zydus' phase 3 liver disease win tees up filing to challenge Gilead and Ipsen | ||
| 29.08. | After trial failure, J&J ditches Imaavy as combo agent for rheumatoid arthritis | ||
| 29.08. | Pfizer to discontinue low-dose ATTR drug Vyndaqel in US ahead of 2028 patent loss | ||
| 29.08. | Lilly links up with JD Health for DTC obesity, diabetes drug sales in China | ||
| 29.08. | University of Michigan sues AstraZeneca, targeting 'master strains' used in FluMist | ||
| 28.08. | With Saxenda generic, Teva launches first copycat GLP-1 for obesity | ||
| 28.08. | German generics maker Stada eyes fall IPO, CEO says: report | ||
| 28.08. | Leukemia & Lymphoma Society rebrands, launches first national campaign in a decade | ||
| 28.08. | Virginia lawmakers endorse development packages for AstraZeneca, Lilly manufacturing plants: report | ||
| 28.08. | Eli Lilly pauses UK Mounjaro orders ahead of price hike, citing stockpiling concerns | ||
| 28.08. | Maze Therapeutics referred to federal marketing regulators over challenge brought by Vertex |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .